{
    "id": 28257,
    "fullName": "FGFR3 G384D",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "FGFR3 G384D (corresponds to G382D in the canonical isoform) lies within the transmembrane domain of the Fgfr3 protein (UniProt.org). G384D results in in increased phosphorylation of Mapk, Stat1, and Stat3, but is not transforming in cell culture (PMID: 11429702), and therefore, is predicted to lead to a gain of Fgfr3 protein function.",
            "references": [
                {
                    "id": 2175,
                    "pubMedId": 11429702,
                    "title": "Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11429702"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2261,
        "geneSymbol": "FGFR3",
        "terms": [
            "FGFR3",
            "ACH",
            "CD333",
            "CEK2",
            "HSFGFR3EX",
            "JTK4"
        ]
    },
    "variant": "G384D",
    "createDate": "05/13/2018",
    "updateDate": "03/19/2020",
    "referenceTranscriptCoordinates": {
        "id": 175986,
        "transcript": "NM_001163213",
        "gDna": "chr4:g.1804399G>A",
        "cDna": "c.1151G>A",
        "protein": "p.G384D",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3276,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, multiple myeloma cells over expressing FGFR3 G384D had reduced sensitivity to AZD4547 in culture, compared to cells with ligand-independent activation of FGFR3 (PMID: 22869148).",
            "molecularProfile": {
                "id": 29849,
                "profileName": "FGFR3 G384D FGFR3 over exp"
            },
            "therapy": {
                "id": 654,
                "therapyName": "AZD4547",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 3319,
                    "pubMedId": 22869148,
                    "title": "Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22869148"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 3277,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, multiple myeloma cells over expressing FGFR3 G384D had reduced sensitivity to AZ8010 in culture, compared to cells with ligand-independent activation of FGFR3 (PMID: 22869148).",
            "molecularProfile": {
                "id": 29849,
                "profileName": "FGFR3 G384D FGFR3 over exp"
            },
            "therapy": {
                "id": 2955,
                "therapyName": "AZ8010",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 3319,
                    "pubMedId": 22869148,
                    "title": "Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22869148"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 3274,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, multiple myeloma cells over expressing FGFR3 G384D had reduced sensitivity to PD173074 in culture, compared to cells with ligand-independent activation of FGFR3 (PMID: 22869148).",
            "molecularProfile": {
                "id": 29849,
                "profileName": "FGFR3 G384D FGFR3 over exp"
            },
            "therapy": {
                "id": 2948,
                "therapyName": "PD173074",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 3319,
                    "pubMedId": 22869148,
                    "title": "Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22869148"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29848,
            "profileName": "FGFR3 G384D",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29849,
            "profileName": "FGFR3 G384D FGFR3 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 175983,
            "transcript": "XM_006713869",
            "gDna": "chr4:g.1804399G>A",
            "cDna": "c.1151G>A",
            "protein": "p.G384D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 175985,
            "transcript": "XM_006713871",
            "gDna": "chr4:g.1804399G>A",
            "cDna": "c.1151G>A",
            "protein": "p.G384D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 175984,
            "transcript": "XM_006713870",
            "gDna": "chr4:g.1804399G>A",
            "cDna": "c.1151G>A",
            "protein": "p.G384D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 175986,
            "transcript": "NM_001163213",
            "gDna": "chr4:g.1804399G>A",
            "cDna": "c.1151G>A",
            "protein": "p.G384D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 175982,
            "transcript": "XM_006713868",
            "gDna": "chr4:g.1804399G>A",
            "cDna": "c.1151G>A",
            "protein": "p.G384D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}